Autopsy report · NCT00440440

Effect of Testosterone Gel Replacement on Fat Mass in Males With Low Testosterone Levels and Diabetes

“study merged with another study”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 4

Sponsor

Diabetes Center of the Southwest

Sponsor type

University, hospital or other

Conditions

Hypogonadism; Diabetes

Interventions

Testosterone gel; placebo

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Use of Magnetic Imaging to Asses the Efficacy of Cap Assisted Colonoscopy in Reducing Looping and Improving Patient Acceptance for the Colonoscopy Procedure
  “The study was incorporated in another study.” (81% match in meaning)
• Neo-Adjuvant Chemotherapy and Conservative Surgery in Cervical Cancer to Preserve Fertility
  “study is merged with CONTESSA study” (75% match in meaning)
• Yttrium Y 90 Anti-CD45 Monoclonal Antibody AHN-12 in Treating Patients With Advanced Leukemia
  “Replaced with another study” (74% match in meaning)
• MT2004-30: Tomotherapy for Solid Tumors
  “Replaced by another study” (73% match in meaning)
• Use of NAVA in Intubated Preterm
  “Another institution performed the study” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.